Author:
Liu Jia,Nagapudi Karthik,Dolton Michael J,Chiang Po-Chang
Reference40 articles.
1. Drug-drug interaction studies: regulatory guidance and an industry per-spective;Prueksaritanont;AAPS J,2013
2. Drug interaction studies: study design, data analysis, and implications for dosing and labeling;Huang;Clin Pharmacol Ther,2007
3. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). 2017. Clinical drug interaction studies — study design, data analysis, and clinical implications. Available at: https://www.regulations.gov/document/FDA-2017-D-5961-0002. Accessed May 26, 2021
4. Prediction of hepatic efflux transporter-mediated drug in-teractions: when is it optimal to measure intracellular unbound fraction of inhibitors?;Guo;J Pharm Sci,2017
5. The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo;Sychev;Drug Des Devel Ther,2018
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献